CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 55 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-30 | CAUWENBERGH GEERT President & CEO | Grant or award | +2,000 | $0.73 | $1K | 52,583 |
| 2016-12-23 | CAUWENBERGH GEERT President & CEO | Grant or award | +3,000 | $0.72 | $2K | 4,500 |
| 2016-12-22 | CAUWENBERGH GEERT President & CEO | Grant or award | +3,000 | $0.75 | $2K | 53,583 |
| 2016-12-16 | CAUWENBERGH GEERT President & CEO | Grant or award | +33,333 | $0.90 | $30K | 50,583 |
| 2016-12-16 | CAUWENBERGH GEERT President & CEO | Grant or award · Common stock warrant | +33,333 | 33,333 | ||
| 2016-12-16 | Pavco Pamela Chief Development Officer | Grant or award | +11,111 | $0.90 | $10K | 17,173 |
| 2016-12-16 | Pavco Pamela Chief Development Officer | Grant or award · Common stock warrant | +11,111 | 11,111 | ||
| 2016-02-10 | Lockshin Curtis Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2016-02-10 | Dorman H. Paul Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2016-02-10 | Brownlie Keith L Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2016-02-10 | Bitterman Robert J Director | Grant or award · Stock option (right to buy) | +16,666 | 16,666 | ||
| 2016-02-10 | CAUWENBERGH GEERT President & CEO | Grant or award · Stock option (right to buy) | +133,000 | 133,000 | ||
| 2016-02-10 | Pavco Pamela Chief Development Officer | Grant or award · Stock option (right to buy) | +66,000 | 66,000 | ||
| 2016-02-10 | Kontulis Caitlin Secretary & Dir. of Finance | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2015-06-22 | CAUWENBERGH GEERT President & CEO | Option exercise | +35,000 | $0.46 | $16K | 172,500 |
| 2015-06-22 | CAUWENBERGH GEERT President & CEO | Option exercise · Overallotment purchase right | −35,000 | 0 | ||
| 2015-06-02 | Pavco Pamela Chief Development Officer | Grant or award | +12,500 | $0.40 | $5K | 33,718 |
| 2015-06-02 | Pavco Pamela Chief Development Officer | Grant or award · Overallotment purchase right | +6,250 | 6,250 | ||
| 2015-06-02 | Pavco Pamela Chief Development Officer | Grant or award · Common stock purchase warrant | +6,250 | 6,250 | ||
| 2015-06-02 | Lockshin Curtis Director | Grant or award | +12,000 | $0.40 | $5K | 13,000 |
Page 10 of 13 · 258 trades